House Judiciary Committee Passes FIRST STEP Act on

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
136
House Judiciary Committee Passes FIRST STEP Act on Bipartisan Vote on Wednesday

Washington, D.C., May 09, 2018 (GLOBE NEWSWIRE) -- May 9, 2018 FOR IMMEDIATE RELEASE:Contact: Jim ForbesDirector of Communications, Prison Fellowship (703) 544-8540 (work) (304) 780-5628 (cell)

  Washington, D.C.— Prison Fellowship  applauds members of the U.S. House Judiciary Committee for today's passage of the FIRST STEP Act in a strong, bipartisan vote.  Reps. Doug Collins and Hakeem Jeffries introduced the prison reform initiative aimed at lowering recidivism and prison populations through rehabilitative programming.  

"Today, we were thrilled to see the House Judiciary Committee pass by voice vote the FIRST STEP Act ( H.R.5682 )," said Craig DeRoche, Senior Vice President of Advocacy and Public Policy with Prison Fellowship. "While this legislation is only a “first step” to advancing criminal justice reform, it is by no means an insignificant step. The safety of our communities is at stake and for more than 180,000 men and women incarcerated in federal prisons, justice and hope hang in the balance."

"The bipartisan FIRST STEP Act would improve the likelihood that men and women in federal prison will leave better prepared to become productive citizens," added DeRoche.  "Through individualized risk assessments and expansion of recidivism-reducing programs for all federal prisoners, community safety will be protected.  These are goals we can all agree on. The sponsors worked tirelessly and courageously to negotiate a bill that reflects their shared values while maintaining a path forward to the President’s desk.  We now urge House leadership to bring the FIRST STEP Act to the House floor within the next two weeks." The FIRST STEP Act will improve the likelihood that men and women in federal prison will leave prepared to become productive citizens through risk assessment, customized programming, and an opportunity to earn time credits toward community corrections. This legislation will also prepare individuals to reenter their communities as responsible citizens by allowing them to serve the final days of their sentences in halfway houses or home confinement, which equips them with support structures as they transition out of custody.  As inmates progress through rehabilitation plans tailored to their needs and approach the end of their sentences, the Bureau of Prisons (BOP) would conduct risk-and-needs assessments more frequently in order to document when individuals have successfully reduced their risk of reoffending and to ensure that the most appropriate resources remain available to them during the reentry process. 

President Trump has demonstrated his readiness to consider prison reforms like those included in the FIRST STEP Act. Earlier this year, a criminal justice roundtable at the White House included groups like Prison Fellowship, Faith & Freedom Coalition, and Right on Crime. The president then used his first State of the Union address to call for “reforming our prisons to help former inmates who have served their time get a second chance at life,” giving people on both sides of the aisle a reason to stand up and applaud.

About Prison Fellowship Prison Fellowship is the nation's largest outreach to prisoners, former prisoners, and their families, and a leading advocate for criminal justice reform. With more than 40 years of experience helping restore men and women behind bars, Prison Fellowship advocates for federal and state criminal justice reforms that transform those responsible for crime, validate victims, and encourage communities to play a role in creating a safe, redemptive, and just society. 

###

Jim Forbes Prison Fellowship 304-780-5628 jim_forbes@pfm.org

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles